InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Mills Kenneth T., Chairman & CEO. Insider active across 1 company, notably REGENXBIO Inc.. Aggregated, 21 filings have been recorded. History available since 24 June 2021. The latest transaction was filed on 27 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mills Kenneth T.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
225,000 shares@ US$13.0965.9% of flowCommon StockSEC:0001652824-26-000002:0
7,768 shares0Common StockSEC:0001562180-25-004351:0
20,602 shares@ US$3.764.9% of flowCommon StockSEC:0001562180-25-003822:0
30,752 shares@ US$3.767.6% of flowCommon StockSEC:0001562180-25-002804:0
36,316 shares@ US$0.852.0% of flowCommon StockSEC:0001562180-24-006146:0
12,221 shares@ US$3.763.0% of flowCommon StockSEC:0001562180-24-005855:0
200 shares@ US$3.760.0% of flowCommon StockSEC:0001562180-24-005798:0
15,000 shares@ US$3.763.7% of flowCommon StockSEC:0001562180-24-004104:0
15,000 shares@ US$3.763.7% of flowCommon StockSEC:0001562180-24-003452:0
15,000 shares@ US$3.763.6% of flowCommon StockSEC:0001562180-24-002771:0
15,000 shares@ US$3.763.7% of flowCommon StockSEC:0001562180-24-001395:0
45,000 shares@ US$3.7610.9% of flowCommon StockSEC:0001562180-24-000544:0
11,357 shares@ US$17.9513.0% of flowCommon StockSEC:0001562180-24-000223:0
43,500 shares@ US$3.7610.5% of flowCommon StockSEC:0001562180-23-008519:0
9,308 shares@ US$22.6813.9% of flowCommon StockSEC:0001562180-23-000221:0
3,636 shares@ US$32.702.8% of flowCommon StockSEC:0001562180-22-000149:0
3,300 shares0Common StockSEC:0001562180-21-007473:0
1,500 shares@ US$3.760.1% of flowCommon StockSEC:0001562180-21-006967:0
1,500 shares@ US$3.760.1% of flowCommon StockSEC:0001562180-21-006147:0
3,000 shares@ US$3.760.3% of flowCommon StockSEC:0001562180-21-005947:0
4,500 shares@ US$3.760.4% of flowCommon StockSEC:0001562180-21-004525:0
21 of 21 declarations
About Mills Kenneth T.
Mills Kenneth T. is President-CEO and a director of REGENXBIO Inc. (XNAS). He has filed 21 forms, and the sampled recent filings cover the period from 2021-06-28 to 2026-01-29, with option exercises as the most frequent transaction type.
